Biopool gets 510(k) for liver tests:
This article was originally published in Clinica
Executive Summary
Biopool (US) has received US FDA clearance to market two liver disease kits - alkaline phosphatase and aspartate aminotransferase. Biopool now has eight FDA approved clinical chemistry reagents and recently purchased California-based instruments manufacturer Source Scientific (see Clinica No 680, p 18).